{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:01:49Z","timestamp":1790492509410,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:00:00Z","timestamp":1484956800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00259-017-3618-3","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T09:29:03Z","timestamp":1484990943000},"page":"1155-1164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-1094","authenticated-orcid":false,"given":"Egesta","family":"Lopci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Riva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Olivari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Raneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Soffietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Piccardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierina","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Ascolese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Rud\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethania","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,21]]},"reference":[{"issue":"Suppl 4","key":"3618_CR1","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","volume":"16","author":"QT Ostrom","year":"2014","unstructured":"Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. Neuro Oncol. 2014;16 Suppl 4:iv1\u2013iv63.","journal-title":"Neuro Oncol"},{"key":"3618_CR2","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1016\/S1470-2045(13)70168-2","volume":"14","author":"M Weller","year":"2013","unstructured":"Weller M, Pfister SM, Hegi ME, Reifenberger G, Stupp R. Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol. 2013;14:e370\u2013e379.","journal-title":"Lancet Oncol"},{"key":"3618_CR3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. The 2016 WHO Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 2016;131:803\u2013820.","journal-title":"Acta Neuropathol"},{"key":"3618_CR4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.2214\/AJR.12.9168","volume":"200","author":"T Nihashi","year":"2013","unstructured":"Nihashi T, Dahabreh IJ, Terasawa T. PET in the clinical management of glioma: evidence map. AJR Am J Roentgenol. 2013;200:654\u2013660.","journal-title":"AJR Am J Roentgenol"},{"key":"3618_CR5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00259-014-2971-8","volume":"42","author":"E Lopci","year":"2015","unstructured":"Lopci E, Franzese C, Grimaldi M, Zucali PA, Navarria P, Simonelli M, et al. Imaging biomarkers in primary brain tumors. Eur J Nucl Med Mol Imaging. 2015;42:597\u2013612.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3618_CR6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/1778.19268","volume":"100","author":"M Schinkelshoek","year":"2014","unstructured":"Schinkelshoek M, Lopci E, Clerici E, Alongi F, Mancosu P, Rodari M, et al. Impact of 11C-methionine positron emission tomography\/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors. Tumori. 2014;100:636\u2013644.","journal-title":"Tumori"},{"key":"3618_CR7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/neuonc\/nov282","volume":"18","author":"U Roelcke","year":"2016","unstructured":"Roelcke U, Wyss MT, Nowosielski M, Rud\u00e0 R, Roth P, Hofer S, et al. Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas. Neuro Oncol. 2016;18:744\u2013751.","journal-title":"Neuro Oncol"},{"key":"3618_CR8","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:1199\u20131208.","journal-title":"Neuro Oncol"},{"key":"3618_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.apradiso.2004.07.006","volume":"62","author":"M Mitterhauser","year":"2005","unstructured":"Mitterhauser M, Wadsak W, Krcal A, Schmaljohann J, Eidherr H, Schmid A, et al. New aspects on the preparation of [11C]methionine. A simple and fast online approach without preparative HPLC. Appl Radiat Isot. 2005;62:441\u2013445.","journal-title":"Appl Radiat Isot"},{"key":"3618_CR10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00259-012-2295-5","volume":"40","author":"AW Glaudemans","year":"2013","unstructured":"Glaudemans AW, Enting RH, Heesters MA, Dierckx RA, van Rheenen RW, Walenkamp AM, et al. Value of 11C-methionine PET in imaging brain tumours and metastases. Eur J Nucl Med Mol Imaging. 2013;40:615\u2013635.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3618_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11060-009-9953-x","volume":"96","author":"N Galldiks","year":"2010","unstructured":"Galldiks N, Kracht LW, Berthold F, Miletic H, Klein JC, Herholz K, et al. [11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors. J Neurooncol. 2010;96:231\u2013239.","journal-title":"J Neurooncol"},{"key":"3618_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuroimage.2007.08.031","volume":"39","author":"L Bello","year":"2008","unstructured":"Bello L, Gambini A, Castellano A, Carrabba G, Acerbi F, Fava E, et al. Motor and language DTI fiber tracking combined with intraoperative subcortical mapping for surgical removal of gliomas. Neuroimage. 2008;39:369\u2013382.","journal-title":"Neuroimage"},{"key":"3618_CR13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO Classification of Tumors of the Central Nervous System. Acta Neuropathol. 2007;114:97\u2013109.","journal-title":"Acta Neuropathol"},{"key":"3618_CR14","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1200\/JCO.2005.04.6078","volume":"24","author":"MJ Bent van den","year":"2006","unstructured":"van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol. 2006;24:2715\u20132722.","journal-title":"J Clin Oncol"},{"key":"3618_CR15","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2967\/jnumed.111.102533","volume":"53","author":"T Singhal","year":"2012","unstructured":"Singhal T, Narayanan TK, Jacobs MP, Bal C, Mantil JC. 11C-methionine PET for grading and prognostication in gliomas: a comparison study with 18F-FDG PET and contrast enhancement on MRI. J Nucl Med. 2012;53:1709\u20131715.","journal-title":"J Nucl Med"},{"key":"3618_CR16","first-page":"1989","volume":"24","author":"M Law","year":"2003","unstructured":"Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24:1989\u20131998.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3618_CR17","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00234-011-0988-2","volume":"54","author":"K Haegler","year":"2012","unstructured":"Haegler K, Wiesmann M, B\u00f6hm C, Freiherr J, Schnell O, Br\u00fcckmann H, et al. New similarity search based glioma grading. Neuroradiology. 2012;54:829\u2013837.","journal-title":"Neuroradiology"},{"key":"3618_CR18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/neuonc\/now008","volume":"18","author":"LE Jalbert","year":"2016","unstructured":"Jalbert LE, Neill E, Phillips JJ, Lupo JM, Olson MP, Molinaro AM, et al. Magnetic resonance analysis of malignant transformation in recurrent glioma. Neuro Oncol. 2016;18:1169\u20131179.","journal-title":"Neuro Oncol"},{"key":"3618_CR19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3171\/jns.2005.103.3.0498","volume":"103","author":"T Nariai","year":"2005","unstructured":"Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishiwata K, et al. Usefulness of L-[methyl-11C]methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg. 2005;103:498\u2013507.","journal-title":"J Neurosurg"},{"key":"3618_CR20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s101430050018","volume":"22","author":"N Sato","year":"1999","unstructured":"Sato N, Suzuki M, Kuwata N, Kuroda K, Wada T, Beppu T, et al. Evaluation of the malignancy of glioma using 11C-methionine positron emission tomography and proliferating cell nuclear antigen staining. Neurosurg Rev. 1999;22:210\u2013214.","journal-title":"Neurosurg Rev"},{"key":"3618_CR21","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3171\/2010.11.JNS10553","volume":"114","author":"N Shinozaki","year":"2011","unstructured":"Shinozaki N, Uchino Y, Yoshikawa K, Matsutani T, Hasegawa A, Saeki N, et al. Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography. J Neurosurg. 2011;114:1640\u20131647.","journal-title":"J Neurosurg"},{"key":"3618_CR22","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.3174\/ajnr.A1242","volume":"29","author":"T Kato","year":"2008","unstructured":"Kato T, Shinoda J, Oka N, Miwa K, Nakayama N, Yano H, et al. Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity. AJNR Am J Neuroradiol. 2008;29:1867\u20131871.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3618_CR23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11060-011-0625-2","volume":"105","author":"P Metellus","year":"2011","unstructured":"Metellus P, Colin C, Taieb D, Guedj E, Nanni-Metellus I, de Paula AM, et al. IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients. J Neurooncol. 2011;105:591\u2013600.","journal-title":"J Neurooncol"},{"key":"3618_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3174\/ajnr.A3173","volume":"34","author":"T Saito","year":"2013","unstructured":"Saito T, Maruyama T, Muragaki Y, Tanaka M, Nitta M, Shinoda J, et al. 11C-methionine uptake correlates with combined 1p and 19q loss of heterozygosity in oligodendroglial tumors. AJNR Am J Neuroradiol. 2013;34:85\u201391.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3618_CR25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clineuro.2014.08.004","volume":"125","author":"Y Okita","year":"2014","unstructured":"Okita Y, Nonaka M, Shofuda T, Kanematsu D, Yoshioka E, Kodama Y, et al. 11C-methionine uptake correlates with MGMT promoter methylation in nonenhancing gliomas. Clin Neurol Neurosurg. 2014;125:212\u2013216.","journal-title":"Clin Neurol Neurosurg"},{"key":"3618_CR26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MNM.0000000000000236","volume":"36","author":"H Choi","year":"2015","unstructured":"Choi H, Bang JI, Cheon GJ, Kim YH, Park CK, Park SH, et al. 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography in relation to methyl-guanine methyltransferase promoter methylation in high-grade gliomas. Nucl Med Commun. 2015;36:211\u2013218.","journal-title":"Nucl Med Commun"},{"key":"3618_CR27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11060-004-2031-5","volume":"71","author":"D Ribom","year":"2005","unstructured":"Ribom D, Schoenmaekers M, Engler H, Smits A. Evaluation of 11C-methionine PET as a surrogate endpoint after treatment of grade 2 gliomas. J Neurooncol. 2005;71:325\u2013332.","journal-title":"J Neurooncol"},{"key":"3618_CR28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00259-004-1598-6","volume":"32","author":"S Kim","year":"2005","unstructured":"Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, et al. 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging. 2005;32:52\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3618_CR29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13139-015-0362-0","volume":"49","author":"MY Yoo","year":"2015","unstructured":"Yoo MY, Paeng JC, Cheon GJ, Lee DS, Chung JK, Kim EE, et al. Prognostic value of metabolic tumor volume on (11)C-methionine PET in predicting progression-free survival in high-grade glioma. Nucl Med Mol Imaging. 2015;49:291\u20137.","journal-title":"Nucl Med Mol Imaging"},{"key":"3618_CR30","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00259-007-0531-1","volume":"35","author":"A Smits","year":"2008","unstructured":"Smits A, Westerberg E, Ribom D. Adding 11C-methionine PET to the EORTC prognostic factors in grade 2 gliomas. Eur J Nucl Med Mol Imaging. 2008;35:65\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3618_CR31","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.50.5.1316","volume":"50","author":"K Herholz","year":"1998","unstructured":"Herholz K, Holzer T, Bauer B, Schr\u00f6der R, Voges J, Ernestus RI, et al. 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology. 1998;50:1316\u20131322.","journal-title":"Neurology"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3618-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3618-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T17:08:12Z","timestamp":1568740092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3618-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,21]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3618"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3618-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,21]]}}}